Nimotuzumab with Intensity Modulated Radiation Therapy (IMRT) in the Concurrent Setting of Locally Advanced Head and Neck Cancers unfit for Chemoradiation. AJBR. 2024;28(2S):7100-7105. doi:10.53555/AJBR.v27i3S.6818